Drug Trial Radar · NCT07476339
REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jun 17, 2026
Primary completion
Jun 17, 2027
Study completion Jun 17, 2027
Sponsor
- Lead sponsor
- CAN Community HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Gilead Sciences; Midway Specialty Care Center; Costello Medical Inc.
- First posted
- Mar 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Managing HIV well requires taking antiretroviral therapy (ART) every day, but many people living with HIV experience interruptions in their treatment. These pauses in medication can happen for many reasons, such as side effects, challenges with getting to the clinic, personal circumstances, stigma, or difficulties with everyday life. When HIV treatment is stopped, the viral load can increase, which may affect a person's health and make it easier for HIV to be passed on to others. Restarting treatment quickly after an interruption is important for both personal and public health. However, it can be difficult for people who miss doses to get back on treatment right away. There are often several steps and medical appointments required before restarting, such as waiting for lab results or reviewing medical history, which can cause further delays. These additional steps can make it even harder for people to re-engage and may discourage them from returning to care. The REINITIATE study is designed for people living with HIV who have not taken any antiretroviral medications for at least the last 12 weeks. The study will offer participants a way to restart their HIV therapy quickly, by beginning treatment with B/F/TAF on the same day that they return to care. B/F/TAF is a widely used, once-daily HIV regimen, and is recommended in national treatment guidelines. Researchers want to find out if this rapid restart approach is safe and effective, and whether it helps people regain control of HIV and remain in care. The study will also examine how many participants are able to keep the virus at a low level (viral suppression), stay engaged in their HIV care, and tolerate the medication after rapidly restarting treatment. In addition, the study will include interviews with some participants, to gain a better understanding of why they stopped taking their medications and what supported their return to treatment. These insights could help healthcare teams develop better ways to support people living with HIV in the future.
Conditions
- HIV -1 Infection
- HIV (Human Immunodeficiency Virus)
- HIV
- HIV 1 Infection
Interventions
Bictegravir, emtricitabine, and tenofovir alafenamideDrug
Oral, film-coated tablet containing 50 mg BIC, 200 mg FTC, and 25 mg TAF taken once daily with or without food administered for 24 or 48 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants in Cohort 1 with plasma HIV-1 RNA <50 copies/mLTime frame: Week 24
- Percentage of participants in Cohort 2 with plasma HIV-1 RNA ≥50 copies/mLTime frame: Week 24
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
CAN Community Health
Clearwater, Florida · Recruiting
Midway Specialty Care Center
Ft. Pierce, Florida · Recruiting
CAN Community Health
Jacksonville, Florida · Recruiting
CAN Community Health
Orlando, Florida · Recruiting
Midway Specialty Care Center
Orlando, Florida · Recruiting
CAN Community Health
Sarasota, Florida · Recruiting
CAN Community Health
Tampa, Florida · Recruiting
Midway Specialty Care Center
Temple Terrace, Florida · Recruiting
Midway Specialty Care Center
West Palm Beach, Florida · Recruiting
Midway Specialty Care Center
Wilton Manors, Florida · Recruiting
CAN Community Health
Las Vegas, Nevada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.